Participants
cancer, Cancer
WEST, CANCER, CANCER
This randomized controlled trial was conducted at West Cancer Center and Research Institute (WCCRI) between June 2020 and December 2021. WCCRI is a large comprehensive cancer center with nine clinics and over 70 physicians serving 60% of all patients in the tri‐state area of west Tennessee, north Mississippi, and east Arkansas. The study site is an industry leader in implementing innovative technology to support patient engagement activities aimed at improving patient outcomes. To be eligible, WCCRI patients had to be ≥18 years old, with a confirmed cancer diagnosis within 1 month of chemotherapy initiation, had a valid email address, a smartphone device with a data plan, and were willing to download and use the app. Patients unable to communicate in English were excluded, as only English versions of the surveys and app were available at the time.